IDEX Biometrics ASA
IDXAF
$0.89
$0.69345.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 80.06% | 187.50% | -- | -78.96% | -73.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.88% | 187.50% | -- | -78.96% | -73.01% |
| Cost of Revenue | -8.19% | -61.13% | -71.43% | -75.54% | -64.98% |
| Gross Profit | 503.47% | 66.27% | -125.00% | -84.21% | -87.19% |
| SG&A Expenses | 41.49% | -55.08% | -72.28% | -73.17% | -72.75% |
| Depreciation & Amortization | -72.90% | -95.10% | 135.48% | -87.27% | -65.13% |
| Other Operating Expenses | -29.23% | -54.22% | -18.95% | -7.78% | -23.09% |
| Total Operating Expenses | -12.97% | -65.29% | -51.80% | -50.85% | -51.03% |
| Operating Income | 16.08% | 66.31% | 51.09% | 49.04% | 49.66% |
| Income Before Tax | 1.12% | 27.23% | -172.94% | 68.31% | 26.39% |
| Income Tax Expenses | -- | 100.00% | -- | -2,250.00% | -- |
| Earnings from Continuing Operations | 1.18% | 24.84% | -172.94% | 68.96% | 26.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.18% | 24.84% | -172.94% | 68.96% | 26.35% |
| EBIT | 16.08% | 66.31% | 51.09% | 49.04% | 49.66% |
| EBITDA | 13.44% | 61.02% | 51.60% | 40.41% | 49.98% |
| EPS Basic | -1,266.67% | 91.61% | -105.44% | 96.97% | 99.77% |
| Normalized Basic EPS | -1,271.43% | 100.64% | -105.42% | 96.91% | 99.77% |
| EPS Diluted | -1,266.67% | 91.21% | -105.49% | 96.94% | 99.78% |
| Normalized Diluted EPS | -1,271.43% | 100.64% | -105.43% | 96.91% | 99.77% |
| Average Basic Shares Outstanding | -92.74% | 795.57% | 1,244.44% | 924.96% | 31,512.12% |
| Average Diluted Shares Outstanding | -92.74% | 794.72% | 1,240.76% | 924.96% | 31,512.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |